SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-10-008344
Filing Date
2010-02-16
Accepted
2010-02-16 17:04:29
Documents
2
Group Members
D. E. SHAW & CO., L.P.DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 v174116_sc13ga.htm SC 13G/A 219998
2 v174116_ex-1.htm EX-1 9610
  Complete submission text file 0001144204-10-008344.txt   231508
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Subject) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42126 | Film No.: 10609317
SIC: 2834 Pharmaceutical Preparations

Mailing Address 120 WEST FORTY-FIFTH STREET 39TH FLOOR NEW YORK NY 10036
Business Address 120 WEST FORTY-FIFTH STREET 39TH FLOOR NEW YORK NY 10036 (212) 478-0000
D. E. Shaw Valence Portfolios, L.L.C. (Filed by) CIK: 0001294704 (see all company filings)

IRS No.: 134046559 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A